Related Articles
High expression of microRNA‑500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation
MicroRNA‑181b‑5p insufficiency predicts treatment response failure risk and unfavorable event‑free survival as well as overall survival in acute myeloid leukemia patients
Dynamic changes in the level of WT1 as an MRD marker to predict the therapeutic outcome of patients with AML with and without allogeneic stem cell transplantation
PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia
Integrated analysis and validation reveal CYTH4 as a potential prognostic biomarker in acute myeloid leukemia